Study investigates the association between HPV infections and prostate cancer, revealing that HPV patients have a 2.3-fold increased risk of developing prostate cancer compared to those without HPV.
Medical experts discuss the importance of screening for Lp(a) and ongoing trials targeting this protein. Moreover, other new targets for the treatment of hyperlipidemia are reviewed.